Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 858 of 1,261
  1. US 8507653

    Factor IX moiety-polymer conjugates having a releasable linkage

    Nektar Therapeutics · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  2. US 8507661

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  3. US 8507650

    Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria

    INTEGRATED PLANT GENETICS, INC. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  4. US 8507675

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  5. US 8507552

    Triptolide prodrugs

    Regents of the University of Minnesota · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  6. EP 2623110

    Faktor-XII-Hemmer zur Behandlung neurologischer Entzündungserkrankungen

    CSL BEHRING GMBH [DE] · Granted Aug 7, 2013 · Expires Aug 2, 2033

    granted
  7. US 8501953

    PKM2 modulators for use in the treatment of cancer

    Agios Pharmaceuticals, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  8. US 8501804

    Bicyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  9. US 8501926

    Malaria vaccine

    The United States of America as represented by the Secretary of the Army · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  10. US 8501182

    Monoclonal antibodies that react with the capsule of Bacillus anthracis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  11. US 8501184

    High affinity human antibodies to PCSK9

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  12. US 8501247

    Pest control using natural pest control agent blends

    TYRATECH, INC. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  13. US 8501920

    Nucleic acid sequences encoding peptides with utrophin spectrin-like repeats

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  14. US 8501964

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  15. US 8501930

    Peptide-based in vivo siRNA delivery system

    Arrowhead Madison, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  16. BR PI0714667

    conjugado molecular e respectivo uso

    CERAMOPTEC IND INC [US] · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  17. US 8501722

    Methods and compositions for treating bacterial infection

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  18. US 8501959

    Cycloalkane[B]indole antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  19. US 8501957

    Benzimidazole compounds and their use as anticancer agents

    China Medical University · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  20. US 8501943

    Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor

    Almirall, S.A. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  21. US 8501194

    Vaccine for viruses that cause persistent or latent infections

    The Regents of the University of California · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  22. US 8501229

    Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings

    ATRIUM MEDICAL CORPORATION · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  23. US 8501191

    FGFR2-IIIb fusion proteins and methods of making them

    Five Prime Therapeutics, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  24. US 8501188

    Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.